(Q39579635)

13 September 2017

title

A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations (English)

1 reference

13 September 2017

1 reference

Cannon JP

1

1 reference

13 September 2017

Garey KW

series ordinal

2

1 reference

13 September 2017

Danziger LH

series ordinal

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

13 September 2017

1 reference

13 September 2017

volume

21

1 reference

13 September 2017

issue

9

1 reference

13 September 2017

page(s)

1107-1114

1 reference

The emergence of fungi as major hospital pathogens

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

A four-year review of fatal Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

Antifungal agents. Part I. Amphotericin B preparations and flucytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.13.1107.34613

10.1592/PHCO.21.13.1107.34613

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference